Clinical Trials Directory

Trials / Completed

CompletedNCT00456872

Contrast of Buffered Vs. Unbuffered Lidocaine in Bone Marrow Biopsies

A Contrast of Buffered Vs. Unbuffered Lidocaine in Bone Marrow Biopsies

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
49 (actual)
Sponsor
Ohio State University Comprehensive Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Oncology patients require numerous invasive procedures throughout their disease process including bone marrow biopsies (BMB). BMB.s are performed by a significant number of health care providers. One of the biggest concerns for health care providers is to improve patient comfort. The goal of this study was to reduce pain during BMBs. Specific aims of the study were to determine if there is a difference in patients' perceived pain during injection of the pre-procedure anesthetic when buffered versus unbuffered lidocaine is administered to patient's receiving bone marrow biopsies. A double blind, experimental crossover design was used to examine the difference in pain levels when using buffered versus unbuffered lidocaine prior to the bilateral bone marrow biopsy procedure. Based on a power analysis for a paired t-test, a convenience sample of 48 patients was enrolled into the study. Patients served as their own control. The site of first biopsy, and which lidocaine solution was administered first, were randomized. A 100mm visual analogue scale (VAS) was used to measure pain. All data has been collected, are currently under analysis, and results will be completed in August 2006. Differences in groups will be examined using a paired t-test. A demographic questionnaire was used to gather select demographic variables. Correlative studies will be done to examine the relationship between the patient's perceived pain scores and several exploratory variables. Results of this study may change the current type of anesthetic used pre-BMBs thus improving patient comfort.

Conditions

Interventions

TypeNameDescription
DRUGlidocaine

Timeline

Start date
2004-12-01
Primary completion
2006-05-01
Completion
2007-09-01
First posted
2007-04-05
Last updated
2017-04-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00456872. Inclusion in this directory is not an endorsement.